May 6, 2026 | Uncategorized
JAMA Netw Open. 2026 May 1;9(5):e2611514. doi: 10.1001/jamanetworkopen.2026.11514.ABSTRACTIMPORTANCE: Due to the impact of high-potency synthetic opioids on medication for opioid use disorder (MOUD) initiation, hospital-based addiction clinicians adapted their...
May 3, 2026 | Uncategorized
J Palliat Med. 2026 May 4:10966218261447000. doi: 10.1177/10966218261447000. Online ahead of print.ABSTRACTEating disorders (ED), particularly anorexia nervosa (AN), represent high-morbidity, high-mortality psychiatric illnesses with multisystem medical complications,...
Apr 29, 2026 | Uncategorized
J Subst Use Addict Treat. 2026 Apr 28:209986. doi: 10.1016/j.josat.2026.209986. Online ahead of print.ABSTRACTINTRODUCTION: Higher buprenorphine maintenance doses (>24 mg daily) may be more effective in improving opioid use disorder (OUD) treatment outcomes in the...
Apr 25, 2026 | Uncategorized
J Subst Use Addict Treat. 2026 Apr 24:209998. doi: 10.1016/j.josat.2026.209998. Online ahead of print.ABSTRACTDespite comprising one-fifth of the population, individuals living in rural areas are underrepresented in clinical trials on substance use disorders (SUD)....
Apr 19, 2026 | Uncategorized
JAMA Intern Med. 2026 Apr 20. doi: 10.1001/jamainternmed.2026.0428. Online ahead of print.NO ABSTRACTPMID:42008248 | DOI:10.1001/jamainternmed.2026.0428
Mar 25, 2026 | Uncategorized
J Pain. 2026 Mar 24:106269. doi: 10.1016/j.jpain.2026.106269. Online ahead of print.ABSTRACTChronic pain is common and burdensome among people with end stage kidney disease (ESKD). Pain management options are limited and prescription opioids are often used in this...
